Pharmacokinetics and pharmacodynamics of cannabinoids.
Grotenhermen F.
Clin Pharmacokinet. 2003;42(4):327-60. doi: 10.2165/00003088-200342040-00003.
Cannabis, cannabinoids, and health.
Lafaye G, Karila L, Blecha L, Benyamina A.
Dialogues Clin Neurosci. 2017 Sep;19(3):309-316. doi: 10.31887/DCNS.2017.19.3/glafaye.
Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses.
Breijyeh Z, Jubeh B, Bufo SA, Karaman R, Scrano L.
Toxins (Basel). 2021 Feb 5;13(2):117. doi: 10.3390/toxins13020117.
Drug addiction.
Camí J, Farré M.
N Engl J Med. 2003 Sep 4;349(10):975-86. doi: 10.1056/NEJMra023160.
Demystifying Cannabis: A Review of Its Pharmacology, Use in Pain, and Safety Concerns.
Dume R, Lammers E.
Orthop Nurs. 2020 Jul/Aug;39(4):264-267. doi: 10.1097/NOR.0000000000000679.
[Addictions].
Karila L, Benyamina A.
Rev Mal Respir. 2019 Feb;36(2):233-240. doi: 10.1016/j.rmr.2018.12.001. Epub 2019 Jan 24.
Cannabinoids for Substance Use Disorder Treatment: What Does the Current Evidence Say?
Fernandes JAB, Filev R, Fidalgo TM.
Cannabis Cannabinoid Res. 2023 Oct;8(5):703-715. doi: 10.1089/can.2023.0065. Epub 2023 Jun 1.
The Synthetic Cannabinoids Phenomenon.
Karila L, Benyamina A, Blecha L, Cottencin O, Billieux J.
Curr Pharm Des. 2016;22(42):6420-6425. doi: 10.2174/1381612822666160919093450.
Points & Pearls: Cannabinoids: emerging evidence in use and abuse.
Williams MV, Gupta N, Nusbaum J.
Emerg Med Pract. 2018 Aug 1;20(Suppl 8):1-2.
Cannabinoids: emerging evidence in use and abuse.
Williams MV.
Emerg Med Pract. 2018 Aug;20(8):1-20. Epub 2018 Aug 1.
